Skip to main content
. 2022 Dec 28;8(1):294–300. doi: 10.1177/23969873221148229

Table 3.

Adjusted OR for outcomes.

Adjusted OR (95% CI, p value)
Primary outcomes
 Any parenchymal hemorrhage on follow up imaging* First tertile (TC ⩽ 130 mg/dl) 1.16 (0.99–1.34, p = 0.056)
Second tertile (TC 130–200 mg/dl) 1.25 (1.02–1.53, p = 0.034)
Third tertile (TC ⩾ 200 mg/dl) Ref.
 Moderate or severe CED on follow up imaging § First tertile 1.24 (1.10–1.40, p = 0.003)
Second tertile 1.29 (1.09–1.52, p = 0.001)
Third tertile Ref.
Statins 0.89 (0.79–1.002, p = 0.054)
Secondary outcomes
 SICH NINDS* First tertile (TC ⩽ 130 mg/dl) 1.18 (1.04–1.33, p = 0.012)
Second tertile (TC 130–200 mg/dl) 1.17 (0.98–1.39, p = 0.089)
Third tertile (TC ⩾ 200 mg/dl) Ref.
 SICH ECASS* First tertile 1.31 (1.07–1.6, p = 0.008)
Second tertile 1.37 (1.04–1.8, p = 0.023)
Third tertile Ref.
 SICH SITS-MOST* First tertile 1.04 (0.80–1.46, p = 0.771)
Second tertile 0.902 (0.60–1.35, p = 0.617)
Third tertile Ref.
 Any CED § First tertile 1.19 (1.03–1.38, p = 0.016)
Second tertile 1.25 (1.12–1.39, p < 0.001)
Third tertile Ref.
 Severe CED on follow up imaging § First tertile 1.41 (1.06–1.88, p = 0.018)
Second tertile 1.17 (0.94–1.45, p = 0.159)
Third tertile Ref.
Secondary late outcomes
 mRS 0–2 at 90 days § First tertile (TC ⩽ 130 mg/dl) 0.96 (0.87–1.06, p = 0.43)
Second tertile (TC 130–200 mg/dl) 1.03 (0.9–1.18, p = 0.68)
Third tertile (TC ⩾ 200 mg/dl) Ref.
Statins 1.11 (1.04–1.19, p = 0.003)
 Death at 90 days § First tertile 0.97 (0.85–1.1, p = 0.64)
Second tertile 0.93 (0.78–1.11, p = 0.44)
Third tertile Ref.

Variables in the models

*

: age, NIHSS baseline, SBP baseline, glucose baseline, hypertension, diabetes, previous AF, treatment acetylsalicylic acid, treatment statins, IVT and/or EVT, SBP at 24 h.

§

: age, NIHSS baseline, SBP baseline, glucose baseline, hypertension, diabetes, previous AF, treatment acetylsalicylic acid, treatment statins, IVT and/or EVT, SBP at 24 h, any PH.